April 12, 2024
National Institute of Neurological Disorders and Stroke (NINDS)
This Notice announces the participation of the National Institute of Neurological Disorders and Stroke (NINDS) in NOT-AI-24-007 "Notice of Special Interest (NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH)," effective May 12, 2024.
Changes to the NOSI are shown below:
Currently Reads:
National Institute of Allergy and Infectious Diseases (NIAID)
National Center for Advancing Translational Sciences (NCATS)
National Cancer Institute (NCI)
Research Topics of Interest
NCATS
Delivery of RNA therapeutics and/or genome editors for the treatment of rare diseases; broad spectrum delivery technologies for RNA therapeutics and/or genome editors that go to multiple tissues; technologies to target RNA therapeutics and/or genome editors to specific cells and tissues; delivery technologies based on phages.
Modified to Read:
National Institute of Allergy and Infectious Diseases (NIAID)
National Center for Advancing Translational Sciences (NCATS)
National Cancer Institute (NCI)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Topics of Interest
NCATS
Delivery of RNA therapeutics and/or genome editors for the treatment of rare diseases; broad spectrum delivery technologies for RNA therapeutics and/or genome editors that go to multiple tissues; technologies to target RNA therapeutics and/or genome editors to specific cells and tissues; delivery technologies based on phages.
National Institute of Neurological Disorders and Stroke (NINDS)
The National Institute for Neurological Disorders and Stroke (NINDS) is interested in applications to NOT-AI-24-007 that fall within the NINDS mission space. Particular areas of interest include:
NINDS may decline funding of any application for programmatic or administrative reasons. Potential applicants are strongly encouraged to contact program staff early in the process of preparing a submission. To learn more about the NINDS Small Business Program please visit https://www.ninds.nih.gov/funding/ninds-small-business-program.
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Phone: 301-496-1778
Email: emily.caporello@nih.gov
Financial/Grants Management Contact(s)
Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9231
Email: ChiefGrantsManagementOfficer@ninds.nih.gov
All other aspects of this Notice remain the same.
Please direct all inquiries to:
Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Phone: 301-496-1778
Email: emily.caporello@nih.gov